For instance, a recent study in non-small cell lung cancer [61] evaluated the punctated pattern of LC3B together with p62 expression levels and pointed to the possibility of improved prognosis in the high-LC3B puncta expression group. This evidence concerns the gene MAP1LC3B and non-small cell lung carcinoma.